CA2058288A1 - Compleces metalliques - Google Patents

Compleces metalliques

Info

Publication number
CA2058288A1
CA2058288A1 CA002058288A CA2058288A CA2058288A1 CA 2058288 A1 CA2058288 A1 CA 2058288A1 CA 002058288 A CA002058288 A CA 002058288A CA 2058288 A CA2058288 A CA 2058288A CA 2058288 A1 CA2058288 A1 CA 2058288A1
Authority
CA
Canada
Prior art keywords
hydroxy
pyrone
methyl
carbon atoms
aliphatic hydrocarbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002058288A
Other languages
English (en)
Inventor
Robert C. Hider
Ernst R. Huehns
John B. Porter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2058288A1 publication Critical patent/CA2058288A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002058288A 1990-03-23 1991-03-22 Compleces metalliques Abandoned CA2058288A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9006522.8 1990-03-23
GB909006522A GB9006522D0 (en) 1990-03-23 1990-03-23 Metal complexes

Publications (1)

Publication Number Publication Date
CA2058288A1 true CA2058288A1 (fr) 1991-09-24

Family

ID=10673114

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002058288A Abandoned CA2058288A1 (fr) 1990-03-23 1991-03-22 Compleces metalliques

Country Status (5)

Country Link
EP (1) EP0473764A1 (fr)
JP (1) JPH04506672A (fr)
CA (1) CA2058288A1 (fr)
GB (2) GB9006522D0 (fr)
WO (1) WO1991014664A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258376A (en) * 1989-11-22 1993-11-02 Bernstein Lawrence R Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5574027A (en) * 1989-11-22 1996-11-12 Bernstein; Lawrence R. Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US6004951A (en) * 1989-11-22 1999-12-21 Bernstein; Lawrence Richard Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
DE69132392T2 (de) * 1991-11-12 2001-06-07 Lawrence Richard Bernstein Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen
US5336482A (en) * 1991-12-05 1994-08-09 The Du Pont Merck Pharmaceutical Company Technetium-99m complexes with N-substituted 3-hydroxy-4-pyridinones
US5298525A (en) * 1992-11-23 1994-03-29 University Technologies International, Inc. Diabetes prevention and treatment
GB9711093D0 (en) 1997-05-29 1997-07-23 British Tech Group Novel orally active iron (III) chelators
US6448273B1 (en) 1997-05-29 2002-09-10 Btg International Limited Orally active iron (III) chelators
ES2491891T3 (es) 2004-01-16 2014-09-08 Carnegie Mellon University Marcaje celular para técnicas de resonancia magnética nuclear
EP2010646A2 (fr) 2006-04-14 2009-01-07 Carnegie Mellon University Marquage des cellules et quantification pour les techniques de résonance magnétique nucléaire
JP5645658B2 (ja) 2007-07-10 2014-12-24 カーネギー メロン ユニバーシティー 核磁気共鳴技術のための細胞標識を製造するための組成物及び方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468915A (en) * 1966-04-18 1969-09-23 Pfizer & Co C Novel 2-substituted-6-methylpyromeconic acids
DE2304381C3 (de) * 1973-01-30 1979-06-21 Byk-Mallinckrodt, Chemische Produkte Gmbh, 6057 Dietzenbach Hoch 113m Indium-acetylacetonat enthaltendes Mittel für die szintigraphische Funktionsdiagnostik der Leber auf dessen Herstellung
FR2390408A1 (fr) * 1977-05-11 1978-12-08 Philips France Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
EP0107458B1 (fr) * 1982-10-22 1987-07-29 National Research Development Corporation Compositions pharmaceutiques
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
AU580958B2 (en) * 1983-07-07 1989-02-09 Mallinckrodt, Inc. Sterile radioactive indium-containing aqueous solution

Also Published As

Publication number Publication date
JPH04506672A (ja) 1992-11-19
GB2242191A (en) 1991-09-25
GB9006522D0 (en) 1990-05-23
GB9106137D0 (en) 1991-05-08
GB2242191B (en) 1993-12-08
EP0473764A1 (fr) 1992-03-11
WO1991014664A1 (fr) 1991-10-03

Similar Documents

Publication Publication Date Title
CA2058288A1 (fr) Compleces metalliques
US4452774A (en) Isonitrile radionuclide complexes for labelling and imaging agents
KR910009202B1 (ko) 포르피린 유도체의 제조방법
EP2213666B1 (fr) Dérivé éther de l'acide aromatique ligustrazine, son procédé de préparation, composition pharmaceutique et application
SU1064868A3 (ru) Способ получени тетразолилалкоксикарбостирилов
Rodriguez‐Ubis et al. Lanthanide Complexes of Polyacid Ligands derived from 2, 6‐bis (pyrazol‐1‐yl) pyridine, pyrazine, and 6, 6′‐bis (pyrazol‐1‐yl)‐2, 2′‐bipyridine: Synthesis and luminescence properties
Bauer et al. A comparative evaluation of calix [4] arene-1, 3-crown-6 as a ligand for selected divalent cations of radiopharmaceutical interest
CA2045553C (fr) Procede de preparation d'ethers vinyliques
Hartinger et al. Novel glucose-ferrocenyl derivatives: synthesis and properties
CN104418887A (zh) 一种与磷酸酶反应产生化学发光的化合物、组合物和新型制备方法
US5236902A (en) Method and probes for detecting nucleoside transporter and method for producing the probes
Martin et al. Synthesis and Characterization of 2-Iodo-4-[5′-(4'″-Methylpiperazin-1'″-yl)-2′, 5′-bi-1h-Benzimidazol-2′-Yl] Phenol (iodoHoechst 33258) and 2, 5-Disubstituted Benzimidazole Model Compounds
Cattel et al. New metabolic products of Aspergillus flavus. Part III. Biosynthesis of asperentin
CN102702074A (zh) 一种以咔唑为荧光团的磺酰氯类化合物及其制备方法和用途
US5210270A (en) Method for synthesis and 99m C labelling of 2-alkoxyisobutylisonitrile
Dolphin et al. A convenient and economical preparation of L-methionine-methyl-d3
Talanov et al. Unusual conformational control of mobile mono-and diionizable calix [4] arene ligands by alkali metal cations
Chan et al. Synthesis and biodistribution of radioiodinated‐5‐iodonicotine
US4332946A (en) Resolution enhancing maleimide spin label for biological EPR studies
Saji et al. Synthesis and in vivo behavior of a copper‐64‐labeled dithiosemicarbazone derivative coupled to a dihydropyridine carrier
Liebman et al. Synthesis of olivetol‐4, 6− 14C2, and its conversion to (–)–δ9‐6a, 10a‐trans‐tetrahydrocannabinol‐2, 4− 14C2 via (–)–Δ8‐6a, 10a‐trans‐tetrahydrocannabinol‐2, 4− 14C2
Isaacs et al. Sythesis of deuterium and tritium labeled psoralens
CN108864071A (zh) 一种快速响应的一氧化氮的近红外探针及其制备和生物应用
Dean et al. Usnic acid. Part X. The exploration of a route to 4: 6-dimethoxy-3: 5-dimethylcoumarilic acid
Blake et al. π-Facial Selectivity in the Cycloaddition of Nitrile Oxides to 5, 6-Dideoxy-5-enofuranoses

Legal Events

Date Code Title Description
FZDE Dead